Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Lucideon Bolsters Team to Develop New Antibacterial Materials

Lucideon has welcomed five researchers from the Institute of Biomaterials, Friedrich Alexander University Erlangen in Nuremburg, Germany. The students will research a range of materials with intrinsic antibacterial properties as a part of the HyMedPoly project.

Lucideon is one of nine companies, clinics and universities taking part in the project to develop drug-free antibacterial hybrid biopolymers for medical applications. The areas of research will include wound care and medical device implants. HyMedPoly is a four-year project and has received funding from the EU’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement. Infection is a frequently voiced challenge in orthopaedics, and a variety of initiatives are in development to mitigate it.

Source: Lucideon